Sofia, Bulgaria

Petko D Uzunov

This inventor holds 1 USPTO granted patent. Top assignee: Pharmachim. Active years: 1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Petko D Uzunov. Retrieved from https://idiyas.com/inventor/petko-d-uzunov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Petko D Uzunov: Innovator in Glaucoma Treatment

Introduction

Petko D Uzunov is a notable inventor based in Sofia, Bulgaria. He has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma. His innovative approach has led to the development of a unique antiglaucoma composition.

Latest Patents

Uzunov holds a patent for a composition and method for treating glaucoma. This antiglaucoma composition contains as the active component a s-/-/-2,3 dihydroxy-9,10,11-trimethoxy-5,8,13,13a-tetrahydro-6H-dibenzo (a,f) quinolizine hydrochloride. The composition is designed to be used as an ophthalmic solution, administered in a therapeutic dose of 2 to 3 drops two to four times daily to warm-blooded animals suffering from glaucoma. He has 1 patent to his name.

Career Highlights

Uzunov is associated with Pharmachim, a company that focuses on pharmaceutical innovations. His work at Pharmachim has allowed him to explore and develop new treatments that can significantly improve the quality of life for patients with glaucoma.

Collaborations

Uzunov has collaborated with notable colleagues such as Marko T Markov and Chavdar B Ivanov. Their combined expertise has contributed to the advancement of research and development in the field of ophthalmology.

Conclusion

Petko D Uzunov is a dedicated inventor whose work in glaucoma treatment showcases his commitment to improving healthcare solutions. His innovative patent reflects the potential for advancements in ophthalmic therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…